1. Boro Scopol
2. Boro-scopol
3. Hyoscine
4. Isopto Hyoscine
5. Kwells
6. Scoburen
7. Scopace
8. Scopoderm Tts
9. Scopolamine
10. Scopolamine Cooper
11. Transderm Scop
12. Transderm V
13. Transderm-v
14. Travacalm Ho
15. Vorigeno
1. 114-49-8
2. Scopolamine Hbr
3. Hyoscine Hydrobromide
4. Scopos
5. (-)-scopolamine Hydrobromide
6. Scopolamine (hydrobromide)
7. Beldavrin
8. Scopamin
9. Tranaxine
10. Hyosol
11. Hyoscine Bromide
12. (-)-hyoscine Hydrobromide
13. Scopolaminium Bromide
14. Scopolammonium Bromide
15. Scopine Hydrobromide
16. Euscopol
17. Isoscopil
18. Hysco
19. Kwells
20. (-)-scopolamine Bromide
21. Scopolamine Bromide
22. Scopolamine Hydrobromide Anhydrous
23. R3k67drl3j
24. L-hyoscine Hydrobromide
25. Sereen
26. Mls000069527
27. L-scopolamine-hydrobromide
28. Chebi:61271
29. Smr000058594
30. Dsstox_cid_12029
31. Dsstox_rid_78902
32. Dsstox_gsid_32029
33. Cas-114-49-8
34. Unii-r3k67drl3j
35. Einecs 204-050-6
36. Nsc 61806
37. Nsc-61806
38. Opera_id_496
39. Ec 204-050-6
40. Hyoscine Bromide (anhydrous)
41. Schembl40627
42. Scopolamine Bromide (anhydrous)
43. Chembl3185877
44. Dtxsid0032029
45. Hy-n0296a
46. Scopolaminium Bromide (anhydrous)
47. Regid_for_cid_6603108
48. Scopolammonium Bromide (anhydrous)
49. 672-21-9
50. Scopolamine Hydrobromide (anhydrous)
51. Tox21_110035
52. Tox21_302019
53. (-)-scopolamine Bromide (anhydrous)
54. S2508
55. Scopolamine Hydrobromide [mi]
56. (-)-hyoscine Hydrobromide (anhydrous)
57. Akos015965267
58. Hyoscine Hydrobromide [who-dd]
59. Tox21_110035_1
60. Ac-3389
61. Ccg-268451
62. Cs-2000
63. 1alphah,5alphah-tropan-3-alpha-ol, 5beta,7beta-epoxy-, (-)-tropate (ester), Hydrobromide
64. Ncgc00013722-01
65. Ncgc00024357-07
66. Ncgc00255166-01
67. (-)-scopolamine Hydrobromide (anhydrous)
68. As-35324
69. N2570
70. Sw199343-2
71. 114s498
72. A935283
73. Sr-01000597758
74. Sr-01000597758-1
75. W-108599
76. Q27130957
77. (-)-scopolamine Hydrobromide;hyoscine Hydrobromide;scopine Hydrobromide
78. 1alphah,5alphah-tropan-3alpha-ol, 6beta,7beta-epoxy-, (-)-tropate (ester), Hydrobromide
79. (?,s)-?-(hydroxymethyl)benzeneacetic Acid (1?,2?,4?,5?,7?)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl Ester Hydrobromide
80. (1r,2r,4s,5s,7s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0(2,4)]non-7-yl (2s)-3-hydroxy-2-phenylpropanoate Hydrobromide
81. (1r,2r,4s,5s,7s,9s)-7-{[(2s)-3-hydroxy-2-phenylpropanoyl]oxy}-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.0(2,4)]nonane Bromide
82. 1-alpha-h,5-alpha-h-tropan-3-alpha-ol, 6-beta,7-beta-epoxy-, (-)-tropate (ester), Hydrobromide
83. 6.beta.,7.beta.-epoxy-1.alpha.h,5.alpha.h-tropan-3.alpha.-ol (-)-tropate (ester) Hydrobromide
84. Benzeneacetic Acid, .alpha.-(hydroxymethyl)-, (1.alpha.,2.beta.,4.beta.,5.alpha.,7.beta.)-9-methyl-3-oxa-9-azatricyclo3.3.1.02,4non-7-yl Ester, (.alpha.s)- Hydrobromide
85. Benzeneacetic Acid, Alpha-(hydroxymethyl)-, (1alpha,2beta,4beta,5alpha,7beta)-9-methyl-3-oxa-9-azatricyclo(3.3.1.02,4)non-7-yl Ester, Hydrobromide (1:1), (alphas)-
86. Benzeneacetic Acid, Alpha-(hydroxymethyl)-, (1alpha,2beta,4beta,5alpha,7beta)-9-methyl-3-oxa-9-azatricyclo(3.3.1.02,4)non-7-yl Ester, Hydrobromide, (alphas)-
87. Benzeneacetic Acid, Alpha-(hydroxymethyl)-, 9-methyl-3-oxa-9-azatricyclo(3.3.1.02,4)non-7-yl Ester, Hydrobromide, (7(s)-(1alpha,2beta,4beta,5alpha,7beta))-
Molecular Weight | 384.3 g/mol |
---|---|
Molecular Formula | C17H22BrNO4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 5 |
Exact Mass | 383.07322 g/mol |
Monoisotopic Mass | 383.07322 g/mol |
Topological Polar Surface Area | 62.3 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 418 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Adjuvants, Anesthesia
Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage. (See all compounds classified as Adjuvants, Anesthesia.)
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
Cholinergic Antagonists
Drugs that bind to but do not activate CHOLINERGIC RECEPTORS, thereby blocking the actions of ACETYLCHOLINE or cholinergic agonists. (See all compounds classified as Cholinergic Antagonists.)
Muscarinic Antagonists
Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)
Mydriatics
Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics. (See all compounds classified as Mydriatics.)